IP Library Patent Application 16334167
Patent Application
App. No. 16/334,167

PURIFIED HUMAN MILK OLIGOSACCHARIDES COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/334,167
Abstract

The present invention relates to purified and concentrated human milk oligosaccharide compositions and methods of making and using the same.

Claims (25)

1 . A method of making a purified human milk oligosaccharide composition comprising:

(a) mixing human milk permeate with lactase under conditions suitable for the digestion of lactose in the human milk permeate to create a permeate/lactases mixture;

(b) removing the lactase from the permeate/lactase mixture; and

(c) filtering the mixture to purify and concentrate human milk oligosaccharides.

2 . The method of claim 1 wherein the pH of the permeate is adjusted to a pH of about 4.3 to about 4.7 prior to or concurrent with the addition of the lactase.

3 . The method of claim 2 wherein the pH is adjusted to 4.5 prior to the addition of the lactose.

4 . The method of claim 1 wherein the permeate is heated to a temperature of about 45° C. to about 55° C. prior to or concurrent with the addition of the lactase.

5 . The method of claim 4 wherein the permeate is heated to about 50° C. prior to adding the lactase.

6 . The method of claim 1 wherein lactase is added at about 0.1% to about 0.5% weight/weight.

7 . The method of claim 6 wherein lactase is added at about 0.1% weight/weight.

8 . The method of claim 1 further comprising cooling the mixture to a temperature of about 20° C. to about 30° C. prior to the removal of lactase.

9 . The method of claim 8 wherein the temperature is about 25° C.

10 . The method of claim 1 further comprising clarifying the lactase digested permeate through a depth filter.

11 . The method of claim 10 wherein the depth filter is about 1 to about 5 micron filter.

12 . The method of claim 1 wherein the filtering comprises filtering the mixture of step (b) through a membrane having a pore size of about 50,000 Dalton to create a 50,000 Dalton filtered mixture.

13 . The method of claim 12 further comprising filtering the 50,000 Dalton filtered mixture through a membrane having a pore size of about 2,000 Dalton to about 3,000 Dalton to create a 2,000 to 3,000 Dalton filtered mixture.

14 . The method of claim 12 further comprising filtering the 50,000 Dalton filtered mixture through a membrane having a pore size of ≤600 Dalton.

15 . The method of claim 1 wherein the concentration of human milk oligosaccharides after purification in step (c) is about 1% to about 5% weight/weight.

16 . The method of claim 15 wherein the concentration of human milk oligosaccharides is about 5% weight/weight.

17 . A purified human milk oligosaccharide (HMO) composition made according to the method of claim 1 .

18 . The purified human milk oligosaccharide composition of claim 17 comprising ≤5% lactose.

19 . The purified human milk oligosaccharide composition of claim 17 as shown in FIG. 5E and FIG. 5F .

20 . A method of preventing NEC in a subject in need thereof comprising administering to the subject an effective amount of purified HMO composition of claim 17 .

21 . A method for decreasing systemic inflammation in a subject in need thereof comprising administering to the subject an effective amount of the purified HMO composition of claim 17 .

22 . A method for treating or preventing an infection in a subject in need thereof comprising administering to the subject an effective amount of the purified HMO composition of claim 17 .

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jun 5, 2026
From: HAYFIN SERVICES LLP, AS AGENT
To: PROLACTA BIOSCIENCE, INC.
Reel/Frame 074862/0454 →
SECURITY INTEREST Recorded Dec 21, 2023
From: PROLACTA BIOSCIENCE, INC.
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 065935/0511 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2019
From: SUN, ADAM; LE BOUEDEC, ANNABELLE; HUYNH, TIN D.; TRAN, KIM THU
To: PROLACTA BIOSCIENCE, INC.
Reel/Frame 049658/0107 →